Neurocrine Biosciences (NBIX) Tops Q3 EPS by 75c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $153.04 +0.31%
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Deferred gain on real estate: 853K
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $0.97, $0.75 better than the analyst estimate of $0.22. Revenue for the quarter came in at $258.5 million versus the consensus estimate of $283.04 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- Macquarie Downgrades Tongcheng Travel Holdings Ltd (780:HK) to Neutral
- UBS Upgrades Drax Group Plc. (DRX:LN) (DRXGY) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
